Medical News
Positive Response to New Neoadjuvant Treatment Combination for Gastric and Gastroesophageal Cancer
In a recently published study conducted by the Netherlands Cancer Institute, patients with gastric (stomach) cancer or gastroesophageal junction (G...
Biomarkers and their Role in the Diagnosis and Treatment of Cholangiocarcinoma (CCA)
Researchers in Italy have written a helpful and very detailed review of biomarkers specific to iCCA. Biomarkers are measurable medical signs that c...
COR2ED’s New Resources on Advanced HCC
COR2ED is an independent medical education company that develops impactful educational programmes within specific therapeutic areas. They have rece...
ASCO GI Highlights – Positive Data in Earlier Stage HCC Results
The American Society for Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) was held in San Francisco, USA 18-20 January this year. At ...
Gemcitabine Plus Paclitaxel vs Gemcitabine Alone after FOLFIRINOX in Metastatic Pancreatic Cancer
GEMPAX was an open-label (both researchers and patients know which treatment is being administered), randomised (randomly assigns participants in...
Act4Biosimilars: The Action Plan and Deep Dive Report for Europe are Now Live!
Act4Biosimilars is a global initiative that aims to increase patient access to biologics by facilitating greater Approvability, Accessibility, Acce...
Promising Approach in Treating Rectal Cancer: Rethinking Radiation Before Surgery
Radiation combined with chemotherapy, also known as chemoradiotherapy, is routinely given to people with rectal cancer whose tumours can be removed...
Understanding Metastatic Colorectal Cancer: A Call to Awareness on World Metastatic Colorectal Cancer Day
World Metastatic Colorectal Cancer (mCRC) Day stands as a symbol of hope and determination in the face of the challenges posed by this advanced sta...
Predictive Values of Blood-based RNA Signature for the FOLFIRINOX/FOLFOX Response in Advanced Pancreatic Cancer
Presently, no widely recognised or established biomarkers are specifically designed to predict the effectiveness of FOLFIRINOX/FOLFOX (chemotherape...
DIPLOMA Trial: Minimally Invasive Surgery is an Effective Treatment Option for Early-Stage Pancreatic Cancer
A notable study, DIPLOMA, led by Abu Hilal, M.D., Ph.D., of the Istituto Ospedaliero Fondazione Poliambulanza in Brescia, Italy, involved a large c...
